AdaptVac ApS

CVR 38732730 · Private limited company (ApS) · Active · Low risk

AdaptVac ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.0% over the next 12 months, which is 0.7 times the average for Danish companies. 9 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 10.8m and a net result of DKK -7.1m. CEO: Adam Frederik Sander Bertelsen.

Bankruptcy risk for AdaptVac ApS

1.0%
probability of bankruptcy within 12 months
Low risk

0.7 × the average (1.41%) · higher risk than 72% of active Danish companies

Lowest riskHighest risk

Increases the risk

Return on assets< -20% · bankruptcy rate 16.7%1.9×
Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO changes1 · bankruptcy rate 11.4%1.3×
Municipality changes3+ · bankruptcy rate 10.6%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×
Postcode changes3+ · bankruptcy rate 10.2%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Current ratio150%–200% · bankruptcy rate 5.4%0.61×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
38732730
Status
Active
Company type
Private limited company (ApS)
Founded
(9 years)
Address
Nordre Fasanvej 215
2000 Frederiksberg
Municipality
Frederiksberg
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 50k
Auditor
PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 9
Missing annual reportNo
Negative equityNo
Equity ratio47.0%
Current ratio189%
Moves (last 2 years)0
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address111
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -3.2mDKK 8.4m
Net profitDKK -7.1mDKK 1.7m
EquityDKK 10.8mDKK 17.9m
Total assetsDKK 23.0mDKK 20.0m
CashDKK 9.5m–
Short-term debtDKK 12.2m–
Avg. employees7–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PKF Munkebo Eriksen Funch, Statsautoriseret Revisions aktie selskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025163
1 Jan 2024 – 31 Dec 2024181
1 Jan 2023 – 31 Dec 2023135
1 Jan 2022 – 31 Dec 2022137
1 Jan 2021 – 31 Dec 2021177
1 Jan 2020 – 31 Dec 2020148
1 Jan 2019 – 31 Dec 2019150
1 Jan 2018 – 31 Dec 2018155
22 Jun 2017 – 31 Dec 2017155

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOAdam Frederik Sander BertelsenCurrent
CEOWillem Adriaan De Jongh
BoardAli El-SalantiCurrent
BoardAdam Frederik Sander BertelsenCurrent
BoardMorten Agertoug NielsenCurrent
BoardJacob HjulmandCurrent
BoardMartin Roland JensenCurrent
BoardBent Ulrich Frandsen
BoardWillem Adriaan De Jongh
BoardSteen Søren Klysner
BoardMorten Agertoug Nielsen
BoardAllan Rosetzsky
Owner (50%)NextGen Vaccines Holding ApSCurrent
Owner (33%)EXPRES2ION BIOTECHNOLOGIES ApSCurrent
Owner (50%)EXPRES2ION BIOTECHNOLOGIES ApS
AuditorPKF Munkebo Eriksen Funch, Statsautoriseret RevisionsaktieselskabCurrent
FounderEXPRES2ION BIOTECHNOLOGIES ApSCurrent
FounderNextGen Vaccines Holding ApSCurrent

The CEOs' other companies

Adam Frederik Sander Bertelsen – 1 other companies

Willem Adriaan De Jongh – 3 other companies

Address history (3 moves)

Nordre Fasanvej 215, 2000 Frederiksberg
Ole Maaløes Vej 3, 2200 København N
Agern Alle 1, 2970 Hørsholm
c/o Advokatfirmaet Levin, Algade 34, 1. th, 4000 Roskilde

Other companies at the same address

Similar companies in Frederiksberg

Questions and answers about AdaptVac ApS

Has AdaptVac ApS gone bankrupt?

No, AdaptVac ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of AdaptVac ApS?

Our model estimates a bankruptcy risk of 1.0% over the next 12 months (low risk), which is 0.7 times the average for Danish companies.

Who is the CEO of AdaptVac ApS?

Adam Frederik Sander Bertelsen is the CEO of AdaptVac ApS.

Who is the auditor of AdaptVac ApS?

AdaptVac ApS most recently used PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.

When was AdaptVac ApS founded?

AdaptVac ApS was founded on 22 June 2017.

What is the equity of AdaptVac ApS?

Equity was DKK 10.8m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.